XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Note 7 - Stock-based Compensation and Other Plans (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Jan. 19, 2021
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
The 2018 Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       600,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)   313,750   313,750  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)   0   0  
The 2018 Plan [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Payment Arrangement, Expense   $ 183,000 $ 70,000 $ 282,000 $ 95,000
Share-based Payment Arrangement, Expense, Tax Benefit   46,000 11,000 78,000 17,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total     707,000   707,000
The 2018 Plan [Member] | Restricted Stock [Member]          
Share-based Payment Arrangement, Expense   12,000 0 18,000 0
Share-based Payment Arrangement, Expense, Tax Benefit   3,000 $ 0 4,000 $ 0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total   $ 32,000   $ 32,000  
The 2008 Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)       874,087  
The 2020 Plan [Member] | The 19 Employees [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 125,000        
The 2020 Plan [Member] | Director One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 10,000        
The 2020 Plan [Member] | Each Member of Board of Directors [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 50,000        
The 2020 Plan [Member] | Director Four [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 10,000        
The 2020 Plan [Member] | Director Three [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 10,000        
The 2020 Plan [Member] | Director Two [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 10,000        
The 2020 Plan [Member] | Share-based Payment Arrangement, Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) 35,000        
The 2020 Plan [Member] | SGRP Shares [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) 600,000        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) 550,000        
The 2020 Plan [Member] | SGRP Shares for Each of Up to First Three Additional New Directors During Period December 1, 2020, to April 30, 2021 [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) 50,000        
The 2020 Plan [Member] | SGRP Shares for Three Additional New Directors During Period December 1, 2020, to April 30, 2021 [Member] | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) 700,000